Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07875569 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Opioid Overdose (Trial 3 of 3)

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The study will employ a randomized, parallel-group design with two-stage randomization. After an initial brief screen for basic eligibility, participants will be randomized (within site) to either Remote (R) or In-Person (IP) Intake Groups. During the Intake, detailed consent and eligibility assessment will be completed. Participants who are eligible at the Intake will be randomized (within site and Intake Group) to R or IP Treatment and Assessment Groups. Participants will be followed for 3 months.
Trial Details
NCT Number NCT07875569
Lead Sponsor State University of New York at Buffalo
Collaborators: National Center for Advancing Translational Sciences (NCATS), Wake Forest University Health Sciences, University of Oklahoma
Conditions
(from sponsor)		 Remote vs. In-Person, Remote Visits, In-person Visits
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov